These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 23963114

  • 1. Coordinated targeting of the EGFR signaling axis by microRNA-27a*.
    Wu X, Bhayani MK, Dodge CT, Nicoloso MS, Chen Y, Yan X, Adachi M, Thomas L, Galer CE, Jiffar T, Pickering CR, Kupferman ME, Myers JN, Calin GA, Lai SY.
    Oncotarget; 2013 Sep; 4(9):1388-98. PubMed ID: 23963114
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
    Cai Z, Hao XY, Liu FX.
    Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
    [Abstract] [Full Text] [Related]

  • 3. Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma.
    Koshizuka K, Hanazawa T, Fukumoto I, Kikkawa N, Matsushita R, Mataki H, Mizuno K, Okamoto Y, Seki N.
    J Hum Genet; 2017 Jan; 62(1):113-121. PubMed ID: 27169691
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
    Koshizuka K, Hanazawa T, Kikkawa N, Katada K, Okato A, Arai T, Idichi T, Osako Y, Okamoto Y, Seki N.
    Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Degradation of epidermal growth factor receptor mediates dasatinib-induced apoptosis in head and neck squamous cell carcinoma cells.
    Lin YC, Wu MH, Wei TT, Chuang SH, Chen KF, Cheng AL, Chen CC.
    Neoplasia; 2012 Jun; 14(6):463-75. PubMed ID: 22787428
    [Abstract] [Full Text] [Related]

  • 11. SKLB188 inhibits the growth of head and neck squamous cell carcinoma by suppressing EGFR signalling.
    Barzegar M, Ma S, Zhang C, Chen X, Gu Y, Shang C, Jiang X, Yang J, Nathan CA, Yang S, Huang S.
    Br J Cancer; 2017 Oct 10; 117(8):1154-1163. PubMed ID: 28873083
    [Abstract] [Full Text] [Related]

  • 12. A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-kB regulates head and neck squamous cell carcinoma proliferation.
    Li Z, Yang Z, Passaniti A, Lapidus RG, Liu X, Cullen KJ, Dan HC.
    Oncotarget; 2016 May 31; 7(22):31892-906. PubMed ID: 26895469
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. EGFR-PI3K-AKT-mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy.
    Freudlsperger C, Burnett JR, Friedman JA, Kannabiran VR, Chen Z, Van Waes C.
    Expert Opin Ther Targets; 2011 Jan 31; 15(1):63-74. PubMed ID: 21110697
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Targeting TORC1/2 enhances sensitivity to EGFR inhibitors in head and neck cancer preclinical models.
    Cassell A, Freilino ML, Lee J, Barr S, Wang L, Panahandeh MC, Thomas SM, Grandis JR.
    Neoplasia; 2012 Nov 31; 14(11):1005-14. PubMed ID: 23226094
    [Abstract] [Full Text] [Related]

  • 17. Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer.
    Li Z, Liao J, Yang Z, Choi EY, Lapidus RG, Liu X, Cullen KJ, Dan H.
    Br J Cancer; 2019 Feb 31; 120(3):306-316. PubMed ID: 30585254
    [Abstract] [Full Text] [Related]

  • 18. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.
    Koshizuka K, Nohata N, Hanazawa T, Kikkawa N, Arai T, Okato A, Fukumoto I, Katada K, Okamoto Y, Seki N.
    Oncotarget; 2017 May 02; 8(18):30288-30304. PubMed ID: 28415821
    [Abstract] [Full Text] [Related]

  • 19. Dual blockade of EGFR and c-Met abrogates redundant signaling and proliferation in head and neck carcinoma cells.
    Xu H, Stabile LP, Gubish CT, Gooding WE, Grandis JR, Siegfried JM.
    Clin Cancer Res; 2011 Jul 01; 17(13):4425-38. PubMed ID: 21622718
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.